Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$279,132,585
+$6,599,341 QoQ
Shares Held
1,099,077
-1.4% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
2.79%
of 13F equity value
Holder Rank
#162
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. JNJ ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
|
7,152 | $1,799,729 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,132,585 | 1,099,077 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $272,533,244 | 1,114,929 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $239,864,569 | 1,159,046 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $221,643,836 | 1,195,361 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $185,074,496 | 1,211,617 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $204,793,494 | 1,234,886 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $170,648,996 | 1,179,982 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $200,059,342 | 1,234,477 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $177,287,549 | 1,212,969 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $199,434,720 | 1,260,729 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $143,887,163 | 917,999 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $213,030,489 | 1,367,772 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $275,377,279 | 1,663,710 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $255,048,160 | 1,645,472 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $218,867,230 | 1,238,988 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $265,822,659 | 1,627,220 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $241,617,026 | 1,361,146 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $243,830,021 | 1,375,783 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $222,617,838 | 1,301,326 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $216,605,092 | 1,341,208 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $219,254,772 | 1,330,914 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $202,109,083 | 1,229,748 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $52,349,309 | 332,630 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $59,837,849 | 401,920 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $56,235,827 | 399,885 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $61,492,102 | 468,940 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||